Shafer Christina reported NGNE

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001934412-26-000006

Machine-readable

Structured copy

Timestamps

Event (reported)

May 5, 2026

Published

May 7, 2026

Ingested by INSIDER

Nov 5, 04:00 UTC

Last re-read

Nov 5, 04:00 UTC

Extracted facts

Filer

Shafer Christina

Role

Chief Commercial Officer

Transaction

Grant or awardAs filed: “A”

Asset

Neurogene Inc. — Non-Qualified Stock Option (right to buy)

Ticker

NGNE

Shares

120.0K

Price per share

$0

Execution date (reported)

May 5, 2026

Owned after transaction

120.0K shares

Days from execution to publication

2

What this establishes

Shafer Christina filed this Form 4 reporting a grant or award of NGNE on May 5, 2026. It became public on May 7, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Commercial Officer

Shafer Christinacik:0001934412

Issuer

Neurogene Inc.cik:0001404644

Revision history · 0

No field has changed since this record was first ingested.